Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.70%
#2 aelf aelf +23.60%
#3 Venom Venom +19.06%
#4 Decred Decred +11.55%
#5 Bitway Bitway +10.60%
#6 Pons Pons +10.32%
#7 Wibx Wibx +8.11%
#8 MarsCoin MarsCoin +7.93%
#9 Janction Janction +7.67%
#10 Status Status +7.65%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Vectorite Biomedical Inc. Vectorite Biomedical Inc.

Vectorite Biomedical Inc.

4170
Rank in Stocks #30413
Vectorite Biomedical Inc., established in 1993 and based in New Taipei City,... Vectorite Biomedical Inc., established in 1993 and based in New Taipei City, Taiwan, is a biotechnology firm dedicated to research and development activities globally, including a strong presence in its home country. The company's operations encompass the manufacturing of specialized cell preparation products, in addition to providing full-spectrum services for the collection, processing, and secure storage management of immune cells. These advanced cellular preparations are vital for applications in the medical fields of infectious diseases, inflammatory conditions, and various oncological and tumor-related illnesses.
Share Price
$0.392718
Market Cap
$17.19M
Change (1 day)
0.00%
Change (1 year)
-8.65%
Country
TW
Trade Vectorite Biomedical Inc. (4170)

Category

Healthcare
Earnings for Vectorite Biomedical Inc. (4170)
Earnings in 2026 TTM: 0
According to Vectorite Biomedical Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Vectorite Biomedical Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE